Lentinus Edodes Mycelia Extract
Lentinula edodes mycelia (L.E.M.) is a dried powder extracted from shiitake mushrooms (Lentinula edodes). We previously demonstrated that it has immunomodulatory effects.
Known alternatively as Black Mushroom or Chinese Mushroom, wild Lentinus Edodes grows in Asia only. The name derives from the Shii Tree, its preferred host, although Lentinus Edodes may also grow on oaks and beeches. Lentinus Edodes mushrooms have been cultivated in China and Japan for a thousand years.
Although most westerners are now familiar with Lentinus Edodes as a food mushroom, few know that it's also the most researched health supporting mushroom in Asia. As with other health supporting mushrooms, the research has largely focused on applications against cancer,but also on its anti-viral properties.
The benefit of using Lentinus Edodes mycelium extract as opposed to the mushroom fruit body is that there are compounds in the mycelium that don't exist in the fruiting body or that may be in much higher concentration in the mycelium。
Specification of Lentinus Edodes Mycelia Extract
Product Name: Lentinus Edodes Mycelia Extract
Botanical Name: Lentinus edodes (Berk.)sing
Appearance: Yellow Brown to Brown Fine Powder
Standardized Extract Powder: 10-50% Lentinan
Storage: Store in sealed containers at cool & dry place. Protect from light, moisture and pest infestation.
Shelf life: 2 years when properly stored.
Packing: 1kg/bag, 5kg/bag, 25KG/Drum, or as your requirements.
Payment terms: T/T in advance, Western Union, Paypal, etc.
Leading time: Usually, 3-5 working days after your payment confirmed
Lentinan: a spotlight on the superstar polysaccharide
One of the pharmaceutically active compounds of great interest to scientists- and already being used clinically in Japan- is the shiitake-derived compound lentinan. Perhaps the most intruiging aspect of lentinan use in conjunction with cancer treatment is its apparent ability to improve the quality of life parameters in patients- for example reducing nausea, pain and hair loss. Studies show lentinan to be active against a range of cancers as well as to reduce the symptoms of treatment-related toxicity associated with chemo- and radiotherapy.
Lentinan has been approved for clinical use in Japan since the 1980s, and is currently used as an adjuvant treatment for certain cancers in China and Japan. In randomised, controlled studies lentinan has been reported to increase the survival of patients with advanced gastric17> and colorectal carcinomas in comparison to standard Japanese chemotherapy regimens. Mushroom extract has also demonstrated the ability to inhibit the proliferation of breast cancer cells although further studies are required to confirm these clinical outcomes. Lentinan has also shown significant efficacy in suppressing HIV-1 transcriptase when used in combination with HIV anti-retroviral drug AZT.